bf/NYSE:GMED_icon.jpeg

COM:GLOBUSMEDICAL

Globus Medical

  • Stock

USD

Last Close

84.91

22/11 21:00

Market Cap

9.38B

Beta: -

Volume Today

966.62K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
66.33M
-
80.65M
21.59%
98.10M
21.64%
108.98M
11.08%
110.55M
1.44%
119.83M
8.40%
163.78M
36.68%
212.73M
29.89%
233.08M
9.56%
267.99M
14.98%
573.56M
114.02%
average payables
12.64M
-
17.00M
34.48%
18.62M
9.54%
16.72M
10.18%
21.26M
27.11%
25.47M
19.81%
25.25M
0.83%
21.41M
15.23%
20.08M
6.21%
29.03M
44.56%
46.39M
59.80%
average receivables
61.87M
-
73.17M
18.27%
83.78M
14.50%
91.07M
8.70%
111.42M
22.35%
135.71M
21.80%
153.39M
13.03%
155.26M
1.22%
156.88M
1.04%
191.48M
22.06%
361.09M
88.58%
book value per share
5.10
-
6.21
21.86%
7.53
21.13%
8.70
15.59%
10.06
15.59%
12.11
20.45%
14.14
16.79%
15.28
8.03%
17.29
13.14%
18.38
6.31%
34.88
89.78%
capex per share
-0.26
-
-0.26
2.78%
-0.53
103.29%
-0.43
19.91%
-0.53
24.63%
-0.61
14.41%
-0.71
17.00%
-0.65
9.50%
-0.56
12.53%
-0.74
30.48%
-0.68
7.35%
capex to depreciation
-1.22
-
-1.14
6.79%
-2.11
85.22%
-1.06
49.94%
-1.22
15.58%
-1.43
17.58%
-1.34
6.44%
-1.01
24.53%
-0.81
19.57%
-1.08
33.22%
-0.54
50.15%
capex to operating cash flow
-0.25
-
-0.31
23.42%
-0.42
33.12%
-0.24
42.82%
-0.32
35.12%
-0.33
2.20%
-0.41
25.18%
-0.32
22.16%
-0.21
35.69%
-0.41
101.46%
-0.32
22.52%
capex to revenue
-0.05
-
-0.05
4.26%
-0.09
78.56%
-0.07
22.16%
-0.08
11.21%
-0.08
3.80%
-0.09
7.59%
-0.08
10.44%
-0.06
26.39%
-0.07
21.90%
-0.05
31.06%
cash per share
2.58
-
2.43
5.88%
2.96
21.82%
3.04
2.65%
3.88
27.93%
3.47
10.63%
3.14
9.47%
4.33
37.79%
4.40
1.69%
4.44
0.85%
4.52
1.74%
days of inventory on hand
255.90
-
299.44
17.01%
289.30
3.39%
305.35
5.55%
263.00
13.87%
300.53
14.27%
398.14
32.48%
384.62
3.39%
361.61
5.98%
413.79
14.43%
564.73
36.48%
days payables outstanding
46.30
-
70.01
51.20%
43.90
37.30%
47.34
7.85%
60.74
28.31%
59.29
2.39%
49.92
15.81%
30.56
38.79%
33.50
9.63%
49.96
49.15%
37.73
24.48%
days sales outstanding
54.72
-
62.48
14.17%
57.86
7.40%
61.99
7.14%
72.92
17.64%
73.90
1.34%
75.49
2.14%
68.51
9.24%
63.11
7.89%
77.55
22.88%
117.49
51.51%
debt to assets
0.00
-
0.05
1,305.39%
0.05
8.36%
0.05
8.65%
0.08
-
debt to equity
0.00
-
0.05
1,299.36%
0.06
10.60%
0.05
7.91%
0.11
-
dividend yield
earnings yield
0.04
-
0.04
12.52%
0.04
3.30%
0.04
3.09%
0.03
38.28%
0.04
36.10%
0.03
28.02%
0.02
40.16%
0.02
28.94%
0.03
24.24%
0.02
21.07%
enterprise value
1.78B
-
2.16B
21.23%
2.58B
19.77%
2.24B
13.30%
3.84B
71.26%
4.10B
6.77%
5.64B
37.73%
6.19B
9.71%
7.08B
14.38%
7.31B
3.27%
6.16B
15.72%
enterprise value over ebitda
10.65
-
12.58
18.21%
14.87
18.17%
11.04
25.74%
18.06
63.53%
18.12
0.35%
24.54
35.40%
33.89
38.12%
24.49
27.72%
23.30
4.88%
15.36
34.05%
ev to operating cash flow
19.04
-
27.25
43.13%
21.19
22.25%
13.03
38.49%
24.05
84.52%
22.55
6.22%
32.81
45.47%
31.14
5.09%
25.63
17.70%
40.97
59.86%
25.31
38.23%
ev to sales
4.10
-
4.55
11.03%
4.74
4.29%
3.97
16.26%
6.03
51.87%
5.75
4.76%
7.18
25.03%
7.84
9.20%
7.39
5.81%
7.15
3.27%
3.93
45.04%
free cash flow per share
0.75
-
0.58
23.33%
0.75
29.71%
1.37
82.82%
1.12
17.88%
1.25
10.78%
1.02
18.05%
1.37
34.27%
2.18
58.87%
1.04
52.28%
1.44
38.68%
free cash flow yield
0.04
-
0.02
34.91%
0.03
10.82%
0.06
105.00%
0.03
50.43%
0.03
5.20%
0.02
39.76%
0.02
21.22%
0.03
43.51%
0.01
53.61%
0.03
93.28%
graham net net
2.47
-
2.30
6.84%
2.94
27.77%
3.38
14.75%
4.29
26.94%
4.07
5.03%
4.05
0.43%
4.86
19.94%
4.67
3.95%
5.26
12.73%
2.03
61.48%
graham number
9.22
-
11.71
27.09%
14.18
21.01%
14.61
3.09%
15.89
8.71%
20.87
31.39%
22.32
6.94%
18.89
15.38%
24.00
27.08%
27.98
16.56%
29.00
3.67%
income quality
1.36
-
0.86
37.16%
1.08
26.32%
1.65
52.35%
1.49
9.79%
1.16
21.89%
1.11
4.55%
1.94
75.41%
1.85
4.72%
0.94
49.32%
1.98
111.16%
intangibles to total assets
0.08
-
0.12
47.39%
0.15
20.39%
0.18
20.38%
0.19
3.93%
0.16
13.60%
0.14
16.50%
0.15
7.08%
0.13
12.54%
0.13
0.91%
0.46
268.90%
interest coverage
-171.88
-
-132.07
23.16%
-50.42
61.82%
-24.49
51.43%
-12.75
47.93%
-9.88
22.52%
7.99
180.83%
18.50
131.57%
16.02
13.41%
6.61
58.70%
interest debt per share
-0.01
-
-0.01
60.59%
-0.03
132.96%
-0.07
114.82%
-0.09
30.46%
0.58
744.65%
1.04
80.30%
1.03
1.11%
0.14
86.24%
3.92
2,667.99%
inventory turnover
1.43
-
1.22
14.54%
1.26
3.50%
1.20
5.26%
1.39
16.10%
1.21
12.49%
0.92
24.52%
0.95
3.51%
1.01
6.36%
0.88
12.61%
0.65
26.73%
invested capital
0.00
-
0.05
1,299.36%
0.06
10.60%
0.05
7.91%
0.11
-
market cap
1.87B
-
2.24B
19.80%
2.64B
18.06%
2.37B
10.26%
3.96B
66.69%
4.24B
7.10%
5.84B
37.80%
6.43B
10.13%
7.27B
13.12%
7.46B
2.60%
6.11B
18.13%
net current asset value
322.86M
-
351.93M
9.00%
426.02M
21.05%
418.21M
1.83%
509.62M
21.86%
515.53M
1.16%
557.84M
8.21%
648.58M
16.27%
648.64M
0.01%
753.59M
16.18%
827.25M
9.77%
net debt to ebitda
-0.54
-
-0.48
10.83%
-0.35
27.86%
-0.65
88.87%
-0.56
14.46%
-0.62
10.54%
-0.85
37.69%
-1.31
53.99%
-0.67
49.04%
-0.48
28.22%
0.13
127.62%
net income per share
0.74
-
0.98
32.53%
1.19
20.90%
1.09
8.07%
1.12
2.24%
1.60
43.32%
1.57
2.07%
1.04
33.72%
1.48
42.74%
1.89
27.80%
1.07
43.37%
operating cash flow per share
1.01
-
0.84
16.72%
1.28
52.71%
1.80
40.06%
1.66
7.76%
1.86
11.95%
1.73
6.53%
2.02
16.26%
2.74
36.00%
1.78
35.23%
2.12
19.58%
payables turnover
7.88
-
5.21
33.86%
8.32
59.49%
7.71
7.28%
6.01
22.06%
6.16
2.45%
7.31
18.78%
11.95
63.37%
10.90
8.78%
7.31
32.96%
9.67
32.41%
receivables turnover
6.67
-
5.84
12.41%
6.31
7.99%
5.89
6.66%
5.01
14.99%
4.94
1.33%
4.84
2.10%
5.33
10.18%
5.78
8.56%
4.71
18.62%
3.11
34.00%
research and ddevelopement to revenue
0.06
-
0.07
8.01%
0.07
1.63%
0.08
16.31%
0.07
13.02%
0.08
13.33%
0.08
1.73%
0.11
40.04%
0.10
5.15%
0.07
29.74%
0.08
10.76%
return on tangible assets
0.13
-
0.15
13.47%
0.16
5.94%
0.14
13.71%
0.12
10.74%
0.14
17.18%
0.12
18.40%
0.07
39.21%
0.09
22.55%
0.10
20.01%
0.05
56.99%
revenue per share
4.69
-
5.03
7.36%
5.73
13.85%
5.90
2.88%
6.61
12.06%
7.28
10.23%
7.92
8.75%
8.00
1.05%
9.51
18.83%
10.18
7.04%
13.68
34.40%
roe
0.15
-
0.16
8.76%
0.16
0.19%
0.13
20.47%
0.11
11.54%
0.13
18.99%
0.11
16.15%
0.07
38.64%
0.09
26.17%
0.10
20.22%
0.03
70.16%
roic
0.14
-
0.16
8.89%
0.16
0.33%
0.12
21.79%
0.11
14.04%
0.12
11.74%
0.10
19.40%
0.06
40.34%
0.08
36.47%
0.10
24.72%
0.02
77.34%
sales general and administrative to revenue
0.42
-
0.40
5.76%
0.39
0.76%
0.39
0.26%
0.42
6.91%
0.44
3.78%
shareholders equity per share
5.10
-
6.21
21.86%
7.53
21.13%
8.70
15.59%
10.06
15.59%
12.11
20.45%
14.14
16.79%
15.28
8.03%
17.29
13.14%
18.38
6.31%
34.88
89.78%
stock based compensation to revenue
0.01
-
0.01
25.80%
0.02
18.04%
0.02
14.05%
0.02
14.42%
0.03
33.01%
0.03
8.13%
0.03
3.30%
0.03
6.96%
0.03
0.48%
0.03
4.83%
tangible asset value
424.45M
-
497.73M
17.26%
590.12M
18.56%
664.45M
12.60%
765.23M
15.17%
974.46M
27.34%
1.19B
22.62%
1.26B
5.67%
1.49B
18.25%
1.59B
6.18%
1.64B
3.37%
tangible book value per share
4.58
-
5.28
15.30%
6.21
17.54%
6.95
11.89%
7.95
14.45%
9.96
25.21%
12.05
21.05%
12.81
6.28%
14.82
15.72%
15.78
6.46%
14.30
9.40%
working capital
348.87M
-
380.61M
9.10%
462.11M
21.41%
433.87M
6.11%
527.27M
21.53%
534.56M
1.38%
576.07M
7.76%
700.97M
21.68%
724.35M
3.34%
824.14M
13.78%
1.52B
84.80%

All numbers in USD (except ratios and percentages)